Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

  • You have access
    P-Glycoprotein and Mutlidrug Resistance-Associated Proteins Limit the Brain Uptake of Saquinavir in Mice
    Seonghee Park and Patrick J. Sinko
    Journal of Pharmacology and Experimental Therapeutics March 2005, 312 (3) 1249-1256; DOI: https://doi.org/10.1124/jpet.104.076216
  • You have access
    Renal d-Amino Acid Oxidase Mediates Chiral Inversion of NG-Nitro-d-arginine
    Yan-Fei Xin, Xiang-Jun Zhou, Xi Cheng and Yong-Xiang Wang
    Journal of Pharmacology and Experimental Therapeutics March 2005, 312 (3) 1090-1096; DOI: https://doi.org/10.1124/jpet.104.077123
  • You have access
    Two Major Grapefruit Juice Components Differ in Time to Onset of Intestinal CYP3A4 Inhibition
    Mary F. Paine, Anne B. Criss and Paul B. Watkins
    Journal of Pharmacology and Experimental Therapeutics March 2005, 312 (3) 1151-1160; DOI: https://doi.org/10.1124/jpet.104.076836
  • You have access
    Immunogenicity and Rapid Blood Clearance of Liposomes Containing Polyethylene Glycol-Lipid Conjugates and Nucleic Acid
    Sean C. Semple, Troy O. Harasym, Kathy A. Clow, Steven M. Ansell, Sandra K. Klimuk and Michael J. Hope
    Journal of Pharmacology and Experimental Therapeutics March 2005, 312 (3) 1020-1026; DOI: https://doi.org/10.1124/jpet.104.078113
  • You have access
    Predictive Models of CYP3A4 Heteroactivation: In Vitro-in Vivo Scaling and Pharmacophore Modeling
    Ann-Charlotte Egnell, J. Brian Houston and C. Scott Boyer
    Journal of Pharmacology and Experimental Therapeutics March 2005, 312 (3) 926-937; DOI: https://doi.org/10.1124/jpet.104.078519
  • You have access
    Induction of Drug Metabolism by Forskolin: The Role of the Pregnane X Receptor and the Protein Kinase A Signal Transduction Pathway
    Xunshan Ding and Jeff L. Staudinger
    Journal of Pharmacology and Experimental Therapeutics February 2005, 312 (2) 849-856; DOI: https://doi.org/10.1124/jpet.104.076331
  • You have access
    Circulation Kinetics and Organ Distribution of Hb-Vesicles Developed as a Red Blood Cell Substitute
    Keitaro Sou, Robert Klipper, Beth Goins, Eishun Tsuchida and William T. Phillips
    Journal of Pharmacology and Experimental Therapeutics February 2005, 312 (2) 702-709; DOI: https://doi.org/10.1124/jpet.104.074534
  • You have access
    Liver-Targeted Drug Delivery Using HepDirect Prodrugs
    Mark D. Erion, Paul D. van Poelje, Deidre A. MacKenna, Timothy J. Colby, Annika C. Montag, James M. Fujitaki, David L. Linemeyer and David A. Bullough
    Journal of Pharmacology and Experimental Therapeutics February 2005, 312 (2) 554-560; DOI: https://doi.org/10.1124/jpet.104.075903
  • You have access
    Simultaneous Substitution of Phenylalanine-305 and Aspartate-318 of Rat Pregnane X Receptor with the Corresponding Human Residues Abolishes the Ability to Transactivate the CYP3A23 Promoter
    Xiulong Song, Yuxin Li, Jirong Liu, Madhu Mukundan and Bingfang Yan
    Journal of Pharmacology and Experimental Therapeutics February 2005, 312 (2) 571-582; DOI: https://doi.org/10.1124/jpet.104.074971
  • You have access
    Mechanism-Based Inactivation of CYP3A by HIV Protease Inhibitors
    C. Steven Ernest, Stephen D. Hall and David R. Jones
    Journal of Pharmacology and Experimental Therapeutics February 2005, 312 (2) 583-591; DOI: https://doi.org/10.1124/jpet.104.075416

Pages

  • Previous
  • Next
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 49
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics